IPI-145 |
|
Synonyms: (S)-3-(1-((9H-purin-6-yl)amino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one; IPI-145; IPI 145; IPI-145. INK-1197; INK 1197; INK1197 | |
Cat. No.: I98050 | CAS No.: 1201438-56-3 |
MDL.: | Formula: C22H17ClN6O |
F.W.416.86 | Purity: 99% |
Storage: | |
  |
Catalog Number: | I98050 | CAS No.: | 1201438-56-3 | |
MDL: | Formula: | C22H17ClN6O | ||
F.W.: | 416.86 | Purity: | 99% | |
Package: | Unit: | mg | ||
Appearance: | M.P.: | |||
B.P.: | Density: | |||
Optical Rotation: | Refractive Index: | |||
Solubility: | Stability: | |||
Storage: | Category: | Reference Standard | ||
Application: | IPI-145, also known as INK-1197, is an orally bioavailable, highly selective and potent small molecule inhibitor of the delta and gamma isoforms of phosphoinositide-3 kinase (PI3K) with potential immunomodulating and antineoplastic activities. |